Tekla Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $116M | Buy |
|
|||||
|
2023
Q1 | $118M | Buy |
|
|||||
|
2022
Q4 | $87.2M | Buy |
|
|||||
|
2022
Q3 | $75.1M | Sell |
|
|||||
|
2022
Q2 | $84.5M | Sell |
|
|||||
|
2022
Q1 | $102M | Buy |
|
|||||
|
2021
Q4 | $90.3M | Sell |
|
|||||
|
2021
Q3 | $89.6M | Buy |
|
|||||
|
2021
Q2 | $77.2M | Sell |
|
|||||
|
2021
Q1 | $72.6M | Sell |
|
|||||
|
2020
Q4 | $86.7M | Sell |
|
|||||
|
2020
Q3 | $116M | Buy |
|
|||||
|
2020
Q2 | $117M | Buy |
|
|||||
|
2020
Q1 | $83.4M | Sell |
|
|||||
|
2019
Q4 | $75.6M | Buy |
|
|||||
|
2019
Q3 | $44.3M | Sell |
|
|||||
|
2019
Q2 | $52.3M | Buy |
|
|||||
|
2019
Q1 | $58.1M | Buy |
|
|||||
|
2018
Q4 | $51M | Sell |
|
|||||
|
2018
Q3 | $59.1M | Hold |
|
|||||
|
2018
Q2 | $50.5M | Buy |
|
|||||
|
2018
Q1 | $48.1M | Sell |
|
|||||
|
2017
Q4 | $64.1M | Hold |
|
|||||
|
2017
Q3 | $76.2M | Sell |
|
|||||
|
2017
Q2 | $92.2M | Hold |
|
|||||
|
2017
Q1 | $72.7M | Hold |
|
|||||
|
2016
Q4 | $68.9M | Buy |
|
|||||
|
2016
Q3 | $62M | Hold |
|
|||||
|
2016
Q2 | $53.9M | Hold |
|
|||||
|
2016
Q1 | $55.6M | Hold |
|
|||||
|
2015
Q4 | $83.7M | Hold |
|
|||||
|
2015
Q3 | $71.8M | Sell |
|
|||||
|
2015
Q2 | $95.5M | Hold |
|
|||||
|
2015
Q1 | $84.5M | Sell |
|
|||||
|
2014
Q4 | $81.4M | Buy |
|
|||||
|
2014
Q3 | $67.5M | Sell |
|
|||||
|
2014
Q2 | $54.6M | Sell |
|
|||||
|
2014
Q1 | $63.4M | Sell |
|
|||||
|
2013
Q4 | $71.8M | Hold |
|
|||||
|
2013
Q3 | $81.6M | Sell |
|
|||||
|
2013
Q2 | $62.9M | Buy |
|